Review: Helicobacter pylori and extragastric diseases

Microb Health Dis 2022; 4 (3): e719
DOI: 10.26355/mhd_20229_719

Review: Helicobacter pylori and non-malignant upper gastrointestinal diseases

Microb Health Dis 2022; 4 (3): e721
DOI: 10.26355/mhd_20229_721

Review: Non-Helicobacter pylori Helicobacters

Microb Health Dis 2022; 4 (3): e723
DOI: 10.26355/mhd_20229_723

Review: Diagnosis of Helicobacter pylori infection

Microb Health Dis 2022; 4 (3): e725
DOI: 10.26355/mhd_20229_725

Review: Inflammation, immunology, vaccines

Microb Health Dis 2022; 4 (3): e727
DOI: 10.26355/mhd_20229_727

Review: Epidemiology of Helicobacter pylori infection

Microb Health Dis 2022; 4 (3): e733
DOI: 10.26355/mhd_20229_733

Review: Treatment of Helicobacter pylori infection 2022

Microb Health Dis 2022; 4 (3): e713
DOI: 10.26355/mhd_20229_713

Review: Gastric malignancies – Bugs, pathways and molecular programs

Microb Health Dis 2022; 4 (3): e729
DOI: 10.26355/mhd_20229_729

Review: Helicobacter pylori infection in children

Microb Health Dis 2022; 4 (3): e731
DOI: 10.26355/mhd_20229_731

Biofilm eradication methods and effect of silver and selenium nanoparticles on harmful biofilm forming Staphylococcus Aureus

Microb Health Dis 2022; 4 (2): e703
DOI: 10.26355/mhd_20226_703

Gut microbiota effects in COVID-19 patients accessing the Emergency Department: a 2022-update of gastrointestinal manifestations

Microb Health Dis 2022; 4 (2): e677
DOI: 10.26355/mhd_20224_677

The best strategy for Helicobacter Pylori eradication in people living with HIV in the era of antibiotic resistance

Microb Health Dis 2022; 4 (2): e673
DOI: 10.26355/mhd_20224_673

• Newer
• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• …
• 10
• Older